Document Detail


Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study.
MedLine Citation:
PMID:  20032700     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Despite decreasing cardiac events, perioperative beta-blockade also increases perioperative stroke and mortality. Major bleeding and/or hypotension are independently associated with these outcomes. To investigate the hypothesis that beta-blockade limits the cardiac reserve to compensate for acute surgical anemia, the authors examined the relationship between cardiac events and acute surgical anemia in patients with and without beta-blockade. METHODS: The records of all noncardiac, nontransplant surgical patients between March 2005 and June 2006 were retrospectively retrieved. The primary outcome was a composite that comprised myocardial infarction, nonfatal cardiac arrest, and in-hospital mortality (major adverse cardiac event). The lowest recorded hemoglobin in the first 3 days defined nadir hemoglobin. Propensity scores estimating the probability of receiving a perioperative beta-blocker were used to match (1:1) patients who did or did not receive beta-blockers postoperatively. The relationship between nadir hemoglobin and major adverse cardiac event was then assessed. RESULTS: This analysis identified 4,387 patients in whom nadir hemoglobin could be calculated; 1,153 (26%) patients were administered beta-blockers within the first 24 h of surgery. Propensity scores created 827 matched pairs that were well balanced for all measured confounders. Major adverse cardiac event occurred in 54 (6.5%) beta-blocked patients and in 25 (3.0%) beta-blocker naive patients (relative risk 2.38; 95% CI 1.43-3.96; P = 0.0009). The restricted cubic spline relationship demonstrated that this difference was restricted to those patients in whom the hemoglobin decrease exceeded 35% of the baseline value. CONCLUSIONS: beta-Blocked patients do not seem to tolerate surgical anemia when compared with patients who are naive to beta-blockers. Prospective studies are required to validate these findings.
Authors:
W Scott Beattie; Duminda N Wijeysundera; Keyvan Karkouti; Stuart McCluskey; Gordon Tait; Nicholas Mitsakakis; Gregory M T Hare
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Anesthesiology     Volume:  112     ISSN:  1528-1175     ISO Abbreviation:  Anesthesiology     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-12-24     Completed Date:  2010-01-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1300217     Medline TA:  Anesthesiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  25-33     Citation Subset:  AIM; IM    
Affiliation:
Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada. scott.beattie@uhn.on.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Antagonists / pharmacology*
Adult
Aged
Algorithms
Anemia / etiology,  physiopathology*
Blood Loss, Surgical / physiopathology*
Cardiotonic Agents*
Cohort Studies
Databases, Factual
Heart Arrest / etiology
Hemoglobins / metabolism
Hospital Mortality
Humans
Intraoperative Complications / physiopathology*
Ischemia / physiopathology
Middle Aged
Myocardial Infarction / prevention & control
Prospective Studies
Retrospective Studies
Risk Factors
Survival Analysis
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Cardiotonic Agents; 0/Hemoglobins
Comments/Corrections
Comment In:
Anesthesiology. 2010 Jan;112(1):12-5   [PMID:  20032697 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of dexmedetomidine and propofol on lower esophageal sphincter and gastroesophageal pressure ...
Next Document:  Propofol depresses angiotensin II-induced cell proliferation in rat cardiac fibroblasts.